META vs VRTV: Which Is the Better Buy?

Side-by-side comparison of Meta Platforms, Inc. and Veritiv Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-19.
Meta Platforms, Inc. Β· Communication Services
$665.60
+21.4% upside to fair value
Med Conviction Grade B+ High Quality
VS
Veritiv Corporation Β· Industrials
$169.99
-45.0% upside to fair value
Med Conviction Grade D
QuantHub Verdict
META has more upside to fair value (+21.4%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric META VRTV
Current Price $665.60 $169.99
Fair Value Estimate $808.00 $93.49
Upside to Fair Value +21.4% -45.0%
Market Cap $1,695.6B $2.3B
Forward P/E β€” β€”
EV / EBITDA 16.7x 5.4x
Price / Sales 7.4x 0.4x
Price / FCF 41.3x 10.4x
Revenue Growth YoY +28.0% -19.0%
Gross Margin 81.7% 22.7%
Operating Margin 38.1% 5.9%
Return on Equity 29.7% 48.6%
Dividend Yield 0.32% 1.48%
FCF Yield 2.42% 9.57%
Analyst Consensus Strong Buy Hold
Investment Thesis
META β€” Meta Platforms, Inc.
Meta Platforms operates the Facebook, Instagram, WhatsApp, Messenger and Threads ecosystem, monetizing its unmatched global audience primarily through digital advertising. Business quality is high, supported by 3.60 billion Family daily active people, AI-enhanced ad ranking, 81.7% TTM gross margin, 38.1% TTM operating margin, 29.8% TTM net margin and 29.7% ROE. Revenue grew 28.0% year over year i…
VRTV β€” Veritiv Corporation
Veritiv Corporation is a business-to-business distributor of specialty packaging, facility solutions, print, and publishing products, operating through four segments with a network of distribution centers and roughly 5,000 employees. The business quality is mixed: it generates a strong 48.6% ROE and trades at a low 7.13 trailing P/E and 5.44 EV/EBITDA, but revenue declined 19.0% year over year in…
Accumulation Zones
Metric META VRTV
Zone Low $606.00 $70.12
Zone High $686.80 $79.47
In Buy Zone? Yes No
← META Research    VRTV Research β†’    All Research